Showing 431-440 of 7686 results for "".
Google Maps: It's More Important Than You Think
https://practicaldermatology.com/topics/practice-management/google-maps-it-s-more-important-than-you-think/18997/An Ekwa Marketing education video (Ekwa.com). Google map results are important to provide your practice a page one listing for Google search results and provides a way for patients to find you easily. Google Map listings improve your SEO, too!Cynosure Acquires Ellman International
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-cynosure-acquires-ellman-international/19059/Cynosure Acquires Assets of Ellman International, NPF Ramps Up Patient Advocacy, New App Available for Practice, PLUS: Acne Insights.Injectable Pearl: Microcannulas
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/injectable-pearl-microcannulas/19087/The microcannula is changing the art of aesthetic injectables but it's not right in very situation. Key to success is knowing when to use the cannula versus a needle, says Julius Few, MD.DermwireTV — Valeant Ups Allergan Bid, Nestle Buys Injectables, and Allergan Makes Its Case
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-valeant-ups-allergan-bid-nestle-buys-injectables-and-allergan-makes-its-case/19128/BREAKING NEWS: Valeant has increased its offer for Allergan to $72 per share. Read more. Valeant sells the rights to its aesthetic injectables to Nestle, while Allergan touts physician support and challenges Valeant's business model. In this week's edition of DermWireTV, learn about Valeant's latesLevia Patient Testimonial with Irene
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/levia-patient-testimonial-with-irene/19426/Irene discusses her experiences with psoriasis and Levia. Levia®, from Lerner Medical, provides Personal Targeted Phototherapy® for the self-treatment of psoriasis in the privacy and convenience of a patient's home. Levia incorporates easy to use software for physician control of dosimetry and incluJournal Club: Oral JAK Inhibitors in Moderate-to-Severe AD
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-oral-jak-inhibitors-moderate-severe-ad/24539/Peter Lio, MD, talks with Robert Sidbury, MD, MPH, a dermatologist at Seattle Children's Hospital, about nuanced differences in guideline-recommended use of oral JAK inhibitors in pediatric patients with moderate-to-severe atopic dermatitis (AD) provided in the Annals of Allergy, Asthma, and ImmunolDermWire TV: Factors Affecting Long-term Antibiotic Prescriptions for Acne; Biologics Firm Focusing on Plaque Psoriasis Makes an Important Acquisition; Practical Dermatology Launches Two New Video Series
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-factors-affecting-long-term-antibiotic-prescriptions-acne-biologics-firm-focusing-plaque-psoriasis-makes-important-acquisition-practical-dermatology-launches-two-new-video-series/24319/In this episode of DermWire TV, a new analysis highlights factors affecting long-term antibiotic prescriptions for acne; a company developing plaque psoriasis biologics makes a major acquisition; and Practical Dermatology® launches two new video series focusing on advancing treatment and improving uJournal Club: Blocking IL-4/IL-13 vs JAK/STAT
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-blocking-il-4il-13-vs-jakstat/29101/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, speaks with Editorial Board member Peter Lio, MD, about the Journal of Personalized Medicine article, "Blocking the IL-4/IL-13 Axis versus the JAK/STAT Pathway in Atopic Dermatitis: How Can We Choose?"How Reviews Impact Your Practice Today and Tomorrow
https://practicaldermatology.com/topics/practice-management/how-reviews-impact-your-practice-today-and-tomorrow/19892/Are you harnessing the power of patient reviews? It has never been more important to generate quality reviews from real people. In this video, Ekwa Marketing explores the factors that drive positive reviews. And the opportunities presented by this platform to grow loyalty and attract new patients.Journal Club: Height Improvement After Treatment
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-height-improvement-after-treatment/32406/Practical Dermatology Editorial Board member Peter Lio, MD, talks with Amy Paller, MD, about research into patients with severe atopic dermatitis and lower stature achieving significant improvement in height following treatment with dupilumab.